The expanded platform and new Sitebase solution will be introduced at SCOPE, supporting faster, more accessible clinical research.

FOR IMMEDIATE RELEASE - January 29, 2026: Curebase today announced the expansion of its AI-powered eClinical platform with new innovations designed to accelerate trials and improve data quality. The enhanced platform now includes:

• Curebase Recruit: Advanced patient recruitment capabilities that accelerate enrollment timelines while maintaining data integrity
• eCOA Vigilance: A proprietary AI-powered tool that proactively monitors patient compliance and data quality, shifting from reactive data cleaning to real-time risk management
• Voice AI Agent, Hope: Conversational AI woven throughout the entire platform, from a Voice Receptionist integrated directly into CTMS to natural language scribe for data capture during patient visits
• Enhanced Core Features: Innovations across ePRO, eConsent, EDC, and Participant Engagement

Built entirely in-house with a unified architecture, the platform enables study data to flow seamlessly and error-free between sponsors and sites, resulting in pristine data quality and accelerated timelines.

Hope: AI That Works Across the Entire Platform

Central to this expansion is Hope, Curebase's Voice AI Agent, now embedded throughout the platform. Hope handles inbound patient calls through a Voice Receptionist built directly into CTMS, pre-screens potential participants, captures data through natural conversation during visits, and keeps patients engaged between appointments. Rather than bolting AI onto legacy systems, Hope was designed alongside the platform from day one, creating seamless workflows that feel intuitive for both sites and patients.

"We didn't want to build AI as a separate add-on that study teams have to learn and manage. Hope is simply part of how the platform works. When a patient calls, Hope answers. When data needs capturing, Hope listens. It's AI that disappears into the workflow."— Storm Stillman, CEO of Curebase

Introducing Sitebase: Modern eClinical Technology, Free for Sites

As part of this expansion, Curebase is launching Sitebase, a fundamental shift in how clinical research technology is delivered to sites. The platform includes core technology across Clinical Trial Management (CTMS), Investigator Site Files (eISF), and eSource at no cost to research sites, along with access to Hope's Voice Receptionist.

"Sites deserve to have the most modern software, without breaking the bank. We believe financial barriers and outdated interfaces should never stand in the way of medical progress happening on the ground at clinical research sites."— Storm Stillman, CEO of Curebase

Unlike legacy systems built on decade-old code or patched together through acquisitions, Sitebase offers contemporary technology that's actually easy to use. When sites love their software, studies run more smoothly. For sponsors and CROs, this translates to complete, error-free data and accelerated timelines. For sites, from private independent research centers to large networks, hospitals, and universities, it means modern technology that CRCs and principal investigators actually enjoy using.

By bringing sponsors and sites onto a single platform, Curebase eliminates data silos entirely. Sponsors get higher quality, trusted data. Sites get access to top-tier technology, free, allowing them to focus on what matters most: caring for patients.

See It Live at SCOPE Summit 2026

Curebase will be running live demos at SCOPE Summit 2026 in booth #306. Attendees can experience firsthand how the unified platform creates a better clinical trial ecosystem for everyone.

Storm Stillman will also present "Who's Training on Your Trial? Where Your Data Goes When You Use AI" in the AI in Clinical Research Track on Tuesday, February 3rd, exploring critical considerations for AI safety in clinical trials.

Won't be at SCOPE? You can learn more about the Curebase platform, and actually experience it, at curebase.ai. Join the waitlist for Sitebase at sitebase.ai.

About Curebase

Curebase is reimagining clinical research by building the AI-powered eClinical platform that serves sponsors and sites on a single unified system, giving sites modern technology, sponsors pristine data, and ultimately supporting the acceleration of breakthrough treatments for patients.